NBIX -Long -TP>25%NASDAQ:NBIX
- LONG - RISK 1/5 - TP > 25%
We already have a buy position.
Good luck to everyone...
==============================
NBIX -Long -TP>25%NASDAQ:NBIX
-Long
-TP>25-30% and more
-waiting for a point to enter a long position
Solid Growth but Misses Q2 Earnings TargetsNeurocrine Biosciences Inc. (NASDAQ: NBIX) is continuing to advance its position in the biotech sector, despite facing a slight setback in its Q2 2024 earnings report. The company posted revenue of $590.2 million, which was higher than analyst estimates of $545.9 million, representing a 30.4% year-o
Textbook bullish flagIt looks like a beautiful flag (or pennant) to me, with high volume at the pole and the volume drying up during the consolidation.
I am expecting continuation.
(Potential Trade) NBIX(13 May 2024)
Disclaimer:
All information posted are the author's own trades/potential trades.
The author is not a certified Financial Advisor and do not have the certifications to provide financial advice.
These information are strictly for educational purposes only and do not constitute any finan
NBIX Biotechnology / Pharmaceutical Pre-earnings LONGNeurocrine Biosciences, a mid cap pharmaceutical firm is up for earnings on February 7th.
Investor and trader interest seems to be moderately increasing in the past week. The combined
MACD / RSI indicator is bullish. This looks good for a longtrade to be taken in the premarket
before 7:45 AM
"NBIX Stock Breaks All-Time Highs, Strong Buy Opportunity!"NBIX Stock Breaks All-Time Highs: A Strong Buy Opportunity Emerges
Neurocrine Biosciences Inc. (NBIX) is currently making waves in the stock market as it breaks out of its all-time highs, signaling a promising opportunity for investors. After 14 years of steady upward momentum and price consolidat
Neurocrine Biosciences (NBIX: NASDAQ)Neurocrine Biosciences (NBIX), a biotech company specializing in treatments for neurological, endocrine, and psychiatric disorders, is poised for opportunities in congenital adrenal hyperplasia (CAH). Analysts project NBIX to potentially achieve worldwide revenue of $660 million by fiscal year 2030,
NBIX view(personal)For this stock i have done some deep analysis including looking at the financial reports and estimated points provided by big bank analyst. i have come to the conclusion that after this close below the strong daily support. this pair is likely going to go to the 95 dollar zone within 2 weeks and fr
$NBIX with a bullish outlook following its earnings #StocksThe PEAD projected a bullish outlook for $NBIX after a negative under reaction following its earnings release placing the stock in drift D .
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where NBIX is featured.
